U.S. · HEALTH · NOV 10, 9:43 AM ET
FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss
Reported by 37 outlets in the past day, including Ars Technica, STAT, Fox Business.
1What happened
The Food and Drug Administration now requires warning labels on Ozempic, Wegovy and other GLP-1 drugs over a rare eye condition tied to vision loss. Fox Business ↗
2Also reported
The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.” STAT ↗
Sources
- FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss ↗Ars Technica
- STAT+: GLP-1s are given an FDA warning for rare eye condition risk ↗STAT
- FDA orders new warning labels on Ozempic, Wegovy over rare risk of permanent vision loss ↗Fox Business
- The FDA has a new warning about GLP-1s and vision loss. Should you worry? ↗The Washington Post
- FDA adds rare vision-loss warning to popular GLP-1 drugs ↗AP News
- FDA to require new warning on GLP-1s due to vision loss ↗Greenville Online